Prospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Oncol. Dec 15, 2021; 13(12): 2190-2202
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2190
Table 1 Clinical characteristics of 217 patients
Clinical characteristics
Value
Age, yr, (mean ± SD)52.6 ± 12.4
Sex, n (%)
Male197 (90.8)
Female20 (9.2)
ALT (U/mL)30.2 ± 14.3
AST (U/mL)38.6 ± 32.0
TBiL (μmol/L)15.8 ± 9.6
Child-Pugh score, n (%)
A209 (96.3)
B8 (3.7)
Hepatitis virus, n (%)
HBV178 (82.0)
HCV10 (4.6)
No29 (13.4)
Liver cirrhosis, n (%)
No43 (19.8)
Yes174 (80.2)
ICG-R15 (%)6.6 ± 3.8
AFP (ng/mL), n (%)
≤ 400144 (66.4)
> 40073 (33.6)
Tumor diameter (cm)4.9 ± 3.5
No. of tumor, n (%)
Singe157 (72.4)
Multiple60 (27.6)
Microvascular invasion, n (%)
Yes75 (34.6)
No142 (65.4)
BCLC stage, n (%)
0+A92 (42.4)
B+C125 (57.6)
Operation method, n (%)
Open56 (25.8)
Laparoscopic161 (74.2)
Operation time (min)171 ± 40
Blood loss (mL)160 ± 180
Blood transfusion, n (%)
No189 (87.1)
Yes28 (12.9)
Hepatic vascular occlusion, n (%)
No64 (29.5)
Yes153 (70.5)